Aethlon Medical Inc reports results for the quarter ended June 30 - Earnings Summary

• Aethlon Medical Inc AEMD.OQ reported a quarterly adjusted loss of 85 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-2.72. The mean expectation of three analysts for the quarter was for a loss of 86 cents per share. Wall Street expected results to range from $-1.12 to -68 cents per share.

• Reported revenue was zero​; analysts expected zero.

• Aethlon Medical Inc's reported EPS for the quarter was a loss of 85 cents​.

• The company reported a quarterly loss of $1.76 million.

• Aethlon Medical Inc shares had risen by 5.0% this quarter and lost 81.7% so far this year.

FORECAST CHANGES

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."

• Wall Street's median 12-month price target for Aethlon Medical Inc is $3.03, about 58.3% above its last closing price of $1.26

This summary was machine generated from LSEG data August 13 at 09:15 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)